Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: comment on the article by Saag et al

H.D. van Tuyl, W.F. Lems, A.E. Voskuijl, B.A.C. Dijkmans, M. Boers, P.J.S.M. Kerstens

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)141-142
JournalArthritis & Rheumatism
Volume61
Issue number1
DOIs
Publication statusPublished - 2009

Cite this